Deutsch English Français

Contact

EP1769797

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1769797

EP1769797 - Methods and compositions using cetirizine in combination with leukotriene inhibitors for treating conditions responsive to leukotriene inhibition [Right-click to bookmark this link]
Former [2007/14]	Methods and compositions using cetirizine in combination with leukotriene Inhibitors for treating conditions responsive to leukotriene inhibitiion
	[2007/20]
Status	The application is deemed to be withdrawn Status updated on 16.03.2012 Database last updated on 01.10.2024
Most recent event Tooltip	16.03.2012	Application deemed to be withdrawn	published on 18.04.2012 [2012/16]
Applicant(s)	For all designated states Sepracor Inc. 84 Waterford Drive Marlborough, Massachusetts 01752 / US
	[2007/14]
Inventor(s)	01 / Rubin, Paul, D. 37 Greystone Lane Sudbury, MA 01776 / US
	[2007/14]
Representative(s)	Cowley, Catherine Mary, et al Venner Shipley LLP 200 Aldersgate London EC1A 4HD / GB
	[N/P]
Former [2007/14]	Cowley, Catherine Mary, et al Venner Shipley LLP, 20 Little Britain London EC1A 7DH / GB
Application number, filing date	06123637.8	13.04.1999
	[2007/14]
Priority number, date	US19980059571	14.04.1998 Original published format: US 59571
	[2007/14]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP1769797
	Date:	04.04.2007
	Language:	EN
	[2007/14]
	Type:	A3 Search report
	No.:	EP1769797
	Date:	11.11.2009
	[2009/46]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	12.10.2009
Classification	IPC:	A61K45/06, A61K31/495	[2007/19]
	CPC:	A61K45/06 (EP,US); A61K31/495 (EP,US); A61P11/06 (EP)
	C-Set:	A61K31/495, A61K2300/00 (EP,US); A61K31/495, A61K31/40 (EP,US); A61K31/495, A61K31/405 (US,EP); A61K31/495, A61K31/41 (US,EP); (+) A61K31/495, A61K31/47 (US,EP); A61K31/495, A61K31/475 (EP,US) (-)
	Former IPC [2007/14]	A61K31/495
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2007/14]
Title	German:	Verfahren und Zusammensetzungen unter Verwendung von Cetirizin in Verbindung mit Leukotrienhemmern zum Behandeln von Zuständen, die auf Leukotrienhemmung ansprechen	[2007/14]
	English:	Methods and compositions using cetirizine in combination with leukotriene inhibitors for treating conditions responsive to leukotriene inhibition	[2007/20]
	French:	Procédés et compositions utilisant de la cétirizine en combinaison avec des inhibiteurs de leucotriène pour le traitement des affections répondant à l'inhibition des leucotriènes	[2007/14]
	Former [2007/14]	Methods and compositions using cetirizine in combination with leukotriene Inhibitors for treating conditions responsive to leukotriene inhibitiion
Examination procedure	29.11.2006	Examination requested [2007/14]
	10.12.2009	Amendment by applicant (claims and/or description)
	09.05.2011	Despatch of a communication from the examining division (Time limit: M04)
	20.09.2011	Application deemed to be withdrawn, date of legal effect [2012/16]
	27.10.2011	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2012/16]
Parent application(s) Tooltip	EP99917463.4 / EP1071461
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19990917463) is 01.10.2004
Fees paid	Renewal fee
	29.11.2006	Renewal fee patent year 03
	29.11.2006	Renewal fee patent year 04
	29.11.2006	Renewal fee patent year 05
	29.11.2006	Renewal fee patent year 06
	29.11.2006	Renewal fee patent year 07
	29.11.2006	Renewal fee patent year 08
	12.04.2007	Renewal fee patent year 09
	10.04.2008	Renewal fee patent year 10
	16.04.2009	Renewal fee patent year 11
	25.03.2010	Renewal fee patent year 12
	Penalty fee
	Additional fee for renewal fee
	30.04.2011	13 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]EP0565185 (MERCK FROSST CANADA INC [CA]) [A] 1-52 * page 9, lines 7-11; claim 4 * * page 4, lines 15-27 * * page 3, lines 6-8; claim 8 *;
		[X]EP0780127 (PROCTER & GAMBLE [US]) [X] 14-19,26-31,33,35-38,45-52 * page 2, lines 41,42; example 2 * * page 3, lines 24-30; claims 1,4-6 * * page 4, lines 6-10 * * page 4, columns 38-42 *;
		[E]WO9932125 (SCHERING CORP [US], et al) [E] 1-5,8-11,14-17,20-23,26-29,32-36,43-50* page 1, line 25 - page 3, line 10; claims 1,2,5,7,11,12 *;
		[X] - DA MOTTA ET AL, "Drug Modulation of Antigen-Induced Paw Edema in Guinea Pigs: Effects of Lipopolysaccharide, Tumor Necrosis Factor and Leukocyte Depletion", BRITISH JOURNAL OF PHARMACOLOGY, (199405), vol. 112, no. 1, pages 111 - 116, XP002114975 [X] 45-50 * the whole document *
		[A] - WEG V B ET AL, "HISTAMINE, LEUKOTRIENE D4 AND PLATELET-ACTIVATING FACTOR IN GUINEA PIG PASSIVE CUTANEOUS ANAPHYLAXIS", EUROPEAN JOURNAL OF PHARMACOLOGY, ELSEVIER BV, NL, (19910101), vol. 204, no. 2, ISSN 0014-2999, pages 157 - 163, XP008061880 [A] 1-52 * the whole document * DOI: http://dx.doi.org/10.1016/0014-2999(91)90700-Z

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p